Incidence and Risk Factors for Wound Revision After Surgical Treatment of Spinal Metastasis: A National Population-Based Study in South Korea

Overview

Journal Healthcare (Basel)

Specialty Health Services

Date 2023 Nov 24

PMID 37998455

Authors

Han-Dong Lee

Hae-Dong Jang

Jin-Sung Park

Nam-Su Chung

Hee-Woong Chung

Jin-Young Jun

Kyungdo Han

Jae-Young Hong

Affiliations

Soon will be listed here.

Abstract

Wound complications are commonly seen after surgeries for metastatic spine tumors. While numerous studies have pinpointed various risk factors, there is ongoing debate. Therefore, this study aimed to verify various factors that are still under debate utilizing the comprehensive Korean National Health Insurance Service database. We identified and retrospectively reviewed a cohort of 3001 patients who underwent one of five surgical treatments (corpectomy, decompression and instrumentation, instrumentation only, decompression only, and vertebroplasty) for newly diagnosed spinal metastasis between 2009 and 2017. A Cox regression analysis was performed to determine the risk factors. A total of 197 cases (6.6%) of wound revision were found. Only the surgical method and Charlson comorbidity index were significantly different between the group that underwent wound revision and the group that did not. Regarding surgical methods, the adjusted hazard ratios for decompression only, corpectomy, instrumentation and decompression, and instrumentation only were 1.3, 2.2, 2.2, and 2.4, with these ratios being compared to the vertebroplasty group ( for trend = 0.02). In this regard, based on a sizable South Korean cohort, both surgical methods and medical comorbidity were found to be associated with the wound revision rate among spinal surgery patients for spinal metastasis.

Citing Articles

Determinants of Overall and Readmission-Free Survival in Patients with Metastatic Epidural Spinal Cord Compression.

Pojskic M, Sass B, Bopp M, Wilke S, Nimsky C Cancers (Basel). 2025; 16(24.

PMID: 39766146 PMC: 11674039. DOI: 10.3390/cancers16244248.

Complication avoidance, rehabilitation, pain therapy and palliative care for patients with metastatic spine tumors: WFNS spine committee recommendations.

Pojskic M, Naderi S, Vaishya S, Zileli M, Costa F, Sharif S Neurosurg Rev. 2024; 47(1):830.

PMID: 39476270 PMC: 11525440. DOI: 10.1007/s10143-024-03050-3.

References

Jarvers J, Lange M, Schiemann S, Pfranger J, Heyde C, Osterhoff G . Risk factors for wound-related complications after surgical stabilization of spinal metastases with a special focus on the effect of postoperative radiation therapy. BMC Surg. 2021; 21(1):423. PMC: 8684154. DOI: 10.1186/s12893-021-01431-9. View

Alfonso Olmos M, Gonzalez A, Clemente J, Villas Tome C . Infected vertebroplasty due to uncommon bacteria solved surgically: a rare and threatening life complication of a common procedure: report of a case and a review of the literature. Spine (Phila Pa 1976). 2006; 31(20):E770-3. DOI: 10.1097/01.brs.0000240202.91336.99. View

Choi S, Koo J, Choe D, Kang C . The Incidence and Management Trends of Metastatic Spinal Tumors in South Korea: A Nationwide Population-based Study. Spine (Phila Pa 1976). 2020; 45(14):E856-E863. DOI: 10.1097/BRS.0000000000003445. View

Haubner F, Ohmann E, Pohl F, Strutz J, Gassner H . Wound healing after radiation therapy: review of the literature. Radiat Oncol. 2012; 7:162. PMC: 3504517. DOI: 10.1186/1748-717X-7-162. View

Lee B, Franklin I, Lewis J, Coombes R, Leonard R, Gishen P . The efficacy of percutaneous vertebroplasty for vertebral metastases associated with solid malignancies. Eur J Cancer. 2009; 45(9):1597-602. DOI: 10.1016/j.ejca.2009.01.021. View

Park H, Griffin R, Hui S, Levitt S, Song C . Radiation-induced vascular damage in tumors: implications of vascular damage in ablative hypofractionated radiotherapy (SBRT and SRS). Radiat Res. 2012; 177(3):311-27. DOI: 10.1667/rr2773.1. View

Lakomkin N, Zuckerman S, Stannard B, Montejo J, Sussman E, Virojanapa J . Preoperative Risk Stratification in Spine Tumor Surgery: A Comparison of the Modified Charlson Index, Frailty Index, and ASA Score. Spine (Phila Pa 1976). 2019; 44(13):E782-E787. DOI: 10.1097/BRS.0000000000002970. View

Omeis I, Dhir M, Sciubba D, Gottfried O, McGirt M, Attenello F . Postoperative surgical site infections in patients undergoing spinal tumor surgery: incidence and risk factors. Spine (Phila Pa 1976). 2011; 36(17):1410-9. DOI: 10.1097/BRS.0b013e3181f48fa9. View

Kelly C, Shahrokni A . Moving beyond Karnofsky and ECOG Performance Status Assessments with New Technologies. J Oncol. 2016; 2016:6186543. PMC: 4811104. DOI: 10.1155/2016/6186543. View

10.

Sohn S, Chung C, Han K, Jung J, Hyeun J, Kim J . A Nationwide Study of Surgery in a Newly Diagnosed Spine Metastasis Population. J Korean Neurosurg Soc. 2018; 62(1):46-52. PMC: 6328801. DOI: 10.3340/jkns.2017.0304. View

11.

Khan M, Rooh-ul-Muqim , Zarin M, Khalil J, Salman M . Influence of ASA score and Charlson Comorbidity Index on the surgical site infection rates. J Coll Physicians Surg Pak. 2010; 20(8):506-9. DOI: 08.2010/JCPSP.506509. View

12.

Tarawneh A, Pasku D, Quraishi N . Surgical complications and re-operation rates in spinal metastases surgery: a systematic review. Eur Spine J. 2020; 30(10):2791-2799. DOI: 10.1007/s00586-020-06647-6. View

13.

White A, Fiani B, Jarrah R, Momin A, Rasouli J . Surgical Site Infection Prophylaxis and Wound Management in Spine Surgery. Asian Spine J. 2021; 16(3):451-461. PMC: 9260408. DOI: 10.31616/asj.2020.0674. View

14.

Carl H, Ahmed A, Abu-Bonsrah N, De La Garza Ramos R, Sankey E, Pennington Z . Risk factors for wound-related reoperations in patients with metastatic spine tumor. J Neurosurg Spine. 2018; 28(6):663-668. DOI: 10.3171/2017.10.SPINE1765. View

15.

Barrie U, Montgomery E, Ogwumike E, Pernik M, Luu I, Adeyemo E . Household Income as a Predictor for Surgical Outcomes and Opioid Use After Spine Surgery in the United States. Global Spine J. 2022; 13(8):2124-2134. PMC: 10538313. DOI: 10.1177/21925682211070823. View

16.

Charlson M, Carrozzino D, Guidi J, Patierno C . Charlson Comorbidity Index: A Critical Review of Clinimetric Properties. Psychother Psychosom. 2022; 91(1):8-35. DOI: 10.1159/000521288. View

17.

Schilling A, Ehresman J, Huq S, Ahmed A, Lubelski D, Cottrill E . Risk Factors for Wound-Related Complications After Surgery for Primary and Metastatic Spine Tumors: A Systematic Review and Meta-Analysis. World Neurosurg. 2020; 141:467-478.e3. DOI: 10.1016/j.wneu.2020.03.210. View

18.

Farrokhi M, Nouraei H, Kiani A . The Efficacy of Percutaneous Vertebroplasty in Pain Relief in Patients with Pathological Vertebral Fractures due to Metastatic Spinal Tumors. Iran Red Crescent Med J. 2012; 14(9):523-30. PMC: 3482324. View

19.

Abdelrahman H, Siam A, Shawky A, Ezzati A, Boehm H . Infection after vertebroplasty or kyphoplasty. A series of nine cases and review of literature. Spine J. 2013; 13(12):1809-17. DOI: 10.1016/j.spinee.2013.05.053. View

20.

Charlson M, Pompei P, Ales K, MacKenzie C . A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987; 40(5):373-83. DOI: 10.1016/0021-9681(87)90171-8. View